Table 3.
Cancer survivors | Non-cancer patients | P-value | HR2 | (95% CI) | ||||
---|---|---|---|---|---|---|---|---|
N | Inc1 | N | Inc1 | |||||
Ten most common subsequent diseases in cancer patients | ||||||||
Diabetes mellitus† | 133 | 13.46 | 589 | 14.79 | 0.31 | 0.91 | 0.75 | 1.09 |
Venous thrombosis | ||||||||
Baseline—2 years | 45 | 9.27 | 40 | 2.11 | 0.00 | 4.20 | 2.74 | 6.44 |
2 years—end of follow-up† | 20 | 3.10 | 58 | 2.11 | 0.15 | 1.45 | 0.87 | 2.41 |
Osteoporosis | 99 | 8.93 | 354 | 7.90 | 0.15 | 1.18 | 0.94 | 1.47 |
Chronic obstructive pulmonary disease | 95 | 8.81 | 378 | 8.56 | 0.97 | 1.00 | 0.80 | 1.25 |
Heart failureδ | 94 | 8.31 | 380 | 8.28 | 0.80 | 0.97 | 0.77 | 1.22 |
Stroke/cerebrovascular accident | 92 | 8.27 | 435 | 9.81 | 0.08 | 0.82 | 0.65 | 1.03 |
Dementiaβ | 83 | 7.16 | 417 | 8.93 | 0.07 | 0.81 | 0.64 | 1.02 |
Ischemic heart disease without anginaβ | 71 | 6.76 | 308 | 7.17 | 0.50 | 0.92 | 0.71 | 1.19 |
Ischemic heart disease with angina | 65 | 6.29 | 294 | 7.03 | 0.36 | 0.88 | 0.67 | 1.15 |
Osteoarthrosis hip | 66 | 6.05 | 268 | 6.11 | 0.95 | 1.01 | 0.77 | 1.32 |
Significant differences between cancer and non-cancer patients3 | ||||||||
Hypertension with organ damage | 41 | 3.67 | 250 | 5.55 | 0.01 | 0.66 | 0.48 | 0.92 |
Lipid disorders | ||||||||
Baseline—2 years | 16 | 3.66 | 129 | 7.62 | 0.01 | 0.49 | 0.29 | 0.82 |
2 years—end of follow-up | 31 | 5.27 | 171 | 7.08 | 0.16 | 0.76 | 0.52 | 1.11 |
Benign prostatic hypertrophy | 27 | 5.05 | 223 | 10.87 | 0.00 | 0.46 | 0.31 | 0.69 |
1Inc: incidence per 1000 person years at risk.
2HR: hazard ratio adjusted for sex, age, cardiovascular diseases, respiratory diseases, and diabetes.
3Please see Table 3 in the Supplementary Material on the journal website for all other diseases.
†Adjusted for age as time-varying coefficient.
δAdjusted for sex and age as time-varying coefficient.
βAdjusted for cardiovascular diseases as time-varying coefficient.